Debt Deadline Looms: How Cannabis Companies’ Financial Health Could Impact Your Portfolio – Cansortium (OTC … – Benzinga

Loading…Loading…

Several companies in the cannabis industry are nearing debt maturity dates, which could have profound impacts on their financial strategies and overall stability. A Monday report by Beacon Securities analysts Doug Cooper, MBA; Russell Stanley, CFA, CMT, MBA; and Donangelo Volpe, delves into the potential risks and implications for investors.

Comparative Analysis Of Debt Maturities

Curaleaf CURA leads with the largest upcoming debt maturity, with $475 million due in December 2026, which represents 49% of its total debt of $964 million.

Cresco Labs CRLBF is not far behind, with $400 million maturing in August 2026, accounting for 77% of its $516 million total debt. These significant maturities highlight substantial refinancing risks and necessitate strong cash flow management strategies shortly.

On the other end of the spectrum, VEXTF has a relatively minor upcoming debt maturity of $17 million in July 2027, making up 28% of its total $62 million debt, indicating a potentially less impactful effect on its financial health.

Like VEXT, Jushi Holdings JUSHF also faces a relatively moderate financial situation with an upcoming debt maturity in December 2024, where $58 million is due, accounting for 21% of its total debt of $275 million. This proportion is relatively low compared to other firms in the

Read More

Scroll to Top
Florida Dispensaries